Economic outcomes associated with safety interventions by a pharmacist–adjudicated prior authorization consult service.
This retrospective analysis examined the economic outcomes of a pharmacist-led prior authorization drug request program. Researchers calculated that pharmacist adjudication led to savings in drug costs and also avoided costs related to potential adverse events that were intercepted by pharmacists. They recommend wider use of pharmacist-led formulary management.